For the readers interested in the stock health of Myovant Sciences Ltd. (MYOV). It is currently valued at $19.76. When the transactions were called off in the previous session, Stock hit the highs of $20.80, after setting-off with the price of $17.65. Company’s stock value dipped to $17.4201 during the trading on the day. When the trading was stopped its value was $18.34.
Recently in News on May 11, 2021, Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2021. Fourth fiscal quarter 2020 total revenues of $24.6 million; net product revenue from sales of ORGOVYX in the U.S. of $3.6 million. You can read further details here
Myovant Sciences Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $27.70 on 01/04/21, with the lowest value was $16.69 for the same time period, recorded on 04/13/21.
Myovant Sciences Ltd. (MYOV) full year performance was 53.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Myovant Sciences Ltd. shares are logging -36.05% during the 52-week period from high price, and 71.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $11.55 and $30.90.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1156899 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Myovant Sciences Ltd. (MYOV) recorded performance in the market was -28.46%, having the revenues showcasing -18.62% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.83B, as it employees total of 214 workers.
Market experts do have their say about Myovant Sciences Ltd. (MYOV)
During the last month, 0 analysts gave the Myovant Sciences Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 22.00, with a change in the price was noted -4.44. In a similar fashion, Myovant Sciences Ltd. posted a movement of -18.35% for the period of last 100 days, recording 1,015,100 in trading volumes.
Technical breakdown of Myovant Sciences Ltd. (MYOV)
Raw Stochastic average of Myovant Sciences Ltd. in the period of last 50 days is set at 34.81%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 65.74%. In the last 20 days, the company’s Stochastic %K was 51.01% and its Stochastic %D was recorded 52.36%.
Bearing in mind the latest performance of Myovant Sciences Ltd., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -28.46%. Additionally, trading for the stock in the period of the last six months notably improved by 35.44%, alongside a boost of 53.30% for the period of the last 12 months. The shares increased approximately by -1.25% in the 7-day charts and went down by 15.02% in the period of the last 30 days. Common stock shares were lifted by -18.62% during last recorded quarter.